Resources Repository
-
GuidelinesWeb Portal 2017iDSI Reference Case for Economic Evaluation
This is a reference case which gives 12 principles to guide the planning, conduct and …
This is a reference case which gives 12 principles to guide the planning, conduct and reporting of health economic evaluations in low- and middle-income countries (LMICs). The International Decision Support Group (iDSI) is a network of health, policy and economic experts. It builds on the approaches of the National Institute for Health and Care Excellence (NICE) in the UK, the Health Intervention and Technology Assessment Program (HITAP) in Thailand and the World Health Organization. iDSI…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Priority Setting/Ethics | Costing Methods | Policy/Regulation | Health/Medicine | Global -
ReviewPublication 2017Patients' Preferences in Cancer Treatment: Review of Discrete Choice Experiments
This study aimed to systematically review discrete choice experiments (DCEs) about patients’ preferences for cancer …
This study aimed to systematically review discrete choice experiments (DCEs) about patients’ preferences for cancer treatment and assessed the relative importance of outcome, process and cost attributes. A systematic literature review was conducted using PubMed and EMBASE to identify all DCEs investigating patients’ preferences for cancer treatment between January 2010 and April 2016. Attributes were classified into outcome, process and cost attributes, and their relative importance was assessed. A total of 28 DCEs were identified.…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Preferences/Values | Decision Analysis | Chronic Disease/Risk | Economics/Finance | Health/Medicine | North America | Europe -
OrganizationWeb Portal 2024International Decision Support Initiative (iDSI)
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic …
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise, working to achieve Universal Health Coverage and The Health Sustainable Development Goal (SDG 3). They are committed to robust evidence, analysis and decision-making that policymakers, funders and researchers can use to balance trade-offs between different policy options and model potential results to make the best choice available. They support countries to make better decisions about how much public money…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Priority Setting/Ethics | Costing Methods | Technology Assessment | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | Global -
OrganizationWeb Portal 2024PATH
PATH is an international nonprofit organization that has been translating ideas into health solutions for …
PATH is an international nonprofit organization that has been translating ideas into health solutions for 40 years, with a focus on child survival, maternal and reproductive health, and infectious diseases. PATH mobilizes partners around the world in order to take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. PATH takes a multidimensional approach to solving health challenges, with work spanning five platforms: Vaccines to give children a…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Costing Methods | Technology Assessment | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Social Determinants | Health/Medicine | Global | Sub-Saharan Africa | Asia & Pacific -
OrganizationWeb Portal 2024Agency for Healthcare Research and Quality (AHRQ)
The Agency for Healthcare Research and Quality (AHRQ) is the nation's lead federal agency for …
The Agency for Healthcare Research and Quality (AHRQ) is the nation's lead federal agency for research on health care quality, costs, outcomes and patient safety. AHRQ is the health services research arm of the U.S. Department of Health and Human Services (HHS), complementing the biomedical research mission of its sister agency, the National Institutes of Health. The agency is home to research centers that specialize in major areas of health care research, including: clinical practice…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Costing Methods | Test Performance | Decision Analysis | Technology Assessment | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Mental Health | Injuries/Accidents | Social Determinants | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | Science/Technology | North America -
OrganizationWeb Portal 2024Center for the Evaluation of Value and Risk in Health (CEVR)
CEVR, the Center for the Evaluation of Value and Risk in Health, at Tufts Medical …
CEVR, the Center for the Evaluation of Value and Risk in Health, at Tufts Medical Center was established in 2005 and analyzes the benefits, risks and costs of strategies to improve health and health care. CEVR undertakes projects to determine the cost-effectiveness of health care interventions, including customized analyses for government agencies, private foundations and industry groups. CEVR has developed and maintains two internationally-known databases for health care stakeholders: the Cost-Effectiveness Analysis Registry and the National Coverage Determinations…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Technology Assessment | Health/Medicine | North America -
OrganizationWeb Portal 2024ISPOR
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics …
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) exists to advance the policy, science, and practice of pharmacoeconomics (health economics) and health outcomes research. ISPOR publishes Value in Health, which contains original research articles in the areas of economic evaluation, outcomes research, and conceptual, methodological, and health policy articles. Beyond health economics and outcomes research resources, tools of ISPOR include strategic initiatives, publications, and member…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Preferences/Values | Priority Setting/Ethics | Costing Methods | Value of Information | Mathematical Models | Technology Assessment | Operations Research | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Policy/Regulation | Business/Industry | Economics/Finance | Health/Medicine | Science/Technology | Global -
ReviewPublication 2016Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
This is a systematic review of cost-effectiveness studies reporting cost-per-DALY averted from 2000 through 2015 …
This is a systematic review of cost-effectiveness studies reporting cost-per-DALY averted from 2000 through 2015 conducted using the Global Health Cost-Effectiveness Analysis (GHCEA) Registry. Authors summarized descriptive characteristics on study methodology. They analyzed a) the types of costs included, b) study quality and c) the correlation between diseases researched and the burden of disease in different world regions. 479 cost-per-DALY averted studies were published from 2000 through 2015, with studies from Sub-Saharan Africa representing the largest portion…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Health/Medicine | Global -
GuidelinesPublication 2016Estimating Health-State Utility for Economic Models: ISPOR Task Force Report
Cost-utility models are increasingly used in many countries to establish whether the cost of a …
Cost-utility models are increasingly used in many countries to establish whether the cost of a new intervention can be justified in terms of health benefits. Health-state utility (HSU) estimates (the preference for a given state of health on a cardinal scale where 0 represents dead and 1 represents full health) are typically among the most important and uncertain data inputs in cost-utility models. Clinical trials represent an important opportunity for the collection of health-utility data.…
Cost-Effectiveness Analysis | Health Outcomes | Health Systems | Preferences/Values | Mathematical Models | Technology Assessment | Health/Medicine | Science/Technology | North America | Europe